Find uplifting stories about heroes, innovations, and solutions
3469 results for "covid-19 vaccine"
A single shot that protects against both flu and COVID-19 just got approved in Europe, making vaccinations simpler for millions. The combination vaccine showed stronger immune responses than standard shots in trials with 4,000 adults.
Scientists in Tokyo just made painless, self-administered vaccine patches that work better and stay stable without refrigeration. This breakthrough could help deliver life-saving vaccines to people everywhere, especially in areas without access to cold storage.
Scientists at Stanford Medicine have developed a breakthrough nasal spray vaccine that protects against multiple respiratory threats at once, from COVID-19 and flu to bacterial infections and even allergies. In mice, the experimental vaccine provided months of broad protection by supercharging the lungs' natural defenses instead of targeting specific pathogens.
Getting vaccinated just got simpler for millions. European regulators approved the world's first single-shot vaccine that protects against both COVID-19 and seasonal flu for people 50 and older.
A major Swedish study tracking nearly 60,000 women found no link between COVID-19 vaccination and reduced fertility, putting to rest persistent social media rumors. The research offers reassuring news for anyone who delayed vaccination due to pregnancy concerns.
A new study shows COVID vaccines given in fall and winter 2025-2026 protected older adults from symptomatic illness with 55% effectiveness. The findings highlight a powerful tool many vulnerable seniors are missing out on.
A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.
European regulators just recommended the world's first combined flu and COVID vaccine for people 50 and older. One shot could soon protect against both respiratory illnesses instead of two separate jabs.
A massive study of nearly 14 million children in England just settled a heated debate. COVID infection poses a higher risk of heart problems than the vaccine ever did.
A groundbreaking study of over 1 million veterans reveals that COVID vaccines significantly protect against heart attacks and strokes—even beyond preventing the virus itself. The findings could mean preventing thousands of cardiac events and deaths annually.
Nigeria's ambitious COVID-19 vaccination campaign didn't just protect millions from the virus. It rebuilt the nation's entire immunization infrastructure from the ground up.
Scientists in Singapore developed a nose spray vaccine booster that creates stronger, longer-lasting protection against COVID-19 and related viruses than traditional shots. The breakthrough could mean fewer booster shots and better protection for vulnerable populations.
A rigorous study of 434 toddlers finds no connection between mRNA COVID vaccines during pregnancy and autism or developmental delays. The research offers strong reassurance for expectant mothers making vaccine decisions.
Scientists discovered two blood molecules that can identify lung damage in COVID patients, potentially replacing invasive scans with a quick blood test. Nearly 1,000 hospitalized patients helped unlock this breakthrough that could speed up diagnosis and treatment.
Scientists discovered a natural compound from a Brazilian rainforest tree that blocks COVID-19 at multiple stages, potentially making it harder for the virus to develop resistance. Unlike existing antivirals that target just one weakness, these molecules stop viral entry, replication, and inflammation all at once.
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
Researchers have developed an experimental nasal spray that could protect against multiple respiratory threats at once, from flu and COVID-19 to bacteria and allergens. While still years from market, the innovation represents a major shift in how we might defend ourselves against future pandemics.
Scientists at Stanford Medicine have developed a revolutionary nasal spray vaccine that protects against multiple respiratory threats at once. In mice, the single spray defended against COVID-19, flu, bacterial pneumonia, and even allergies for months.
A global campaign delivered over 100 million vaccine doses to 18.3 million children who missed routine shots during COVID-19, with 12.3 million never vaccinated before. The Big Catch-Up initiative reached kids across 36 countries in Africa and Asia, closing dangerous immunity gaps.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Showing 20 of 3469